We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at where Revolution Medicines, Inc. (NASDAQ:RVMD) stands against the other best ...

Revolution Medicines is a clinical-stage pharma company with a market cap of ~6 billion. Click here to find out why RVMD ...

In this article, we are going to take a look at where Revolution Medicines, Inc. (NASDAQ:RVMD) stands against the other healthcare stocks. McKinsey reported that, since 2019, the US healthcare ...

Revolution Medicines Inc (RVMD) stock soared to a 52-week high, reaching $51.01, marking a significant milestone for the ...

Shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) have received an average rating of “Buy” from the twelve research firms that are currently covering the stock ...

Stifel analyst Benjamin Burnett lowered the firm’s price target on Revolution Medicines (RVMD) to $64 from $78 and keeps a Buy rating on the ...

In trading on Tuesday, shares of Revolution Medicines Inc (Symbol: RVMD) entered into oversold territory, hitting an RSI reading of 28.1, after changing hands as low as $33.25 per share.

REDWOOD CITY, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS ...

In this article, we are going to take a look at where Revolution Medicines, Inc. (NASDAQ:RVMD) stands against the other best mid cap biotech stocks to buy. On March 6, Jared Holz, Mizuho health ...

In this article, we are going to take a look at where Revolution Medicines, Inc. (NASDAQ:RVMD) stands against the other debt free mid cap stocks. Debt-free mid-cap stocks currently offer ...